Loading...
Loading...
Browse all stories on DeepNewz
VisitE11 Bio's Andrew C. Payne Achieves 100x Cost Reduction in Brain Mapping for Curing Disorders with PRISM Technology
Dec 3, 2024, 03:27 PM
E11 Bio has announced a significant advancement in brain mapping technology, achieving a reduction in costs by 100 times. This breakthrough, referred to as PRISM, enables the creation of full brain maps more quickly and efficiently than previously possible. The development is expected to enhance research in connectomics at both human and mouse scales, which is critical for addressing brain disorders, advancing artificial intelligence systems, and simulating human brain functions. The team, led by Andrew C. Payne, has been working diligently on this project, which promises to revolutionize the field of neuroscience and AI.
View original story
Markets
No • 50%
Yes • 50%
Official partnership announcements from E11 Bio or the pharmaceutical company
Yes • 50%
No • 50%
Announcements or press releases from neuroscience research institutions
No • 50%
Yes • 50%
Publication in a peer-reviewed journal or major AI conference
Meta • 25%
Google • 25%
Other • 25%
Microsoft • 25%
Official collaboration announcements from E11 Bio or the tech company
Other • 25%
Asia • 25%
North America • 25%
Europe • 25%
Government or official announcements from national research agencies
Other • 25%
Alzheimer's Disease • 25%
Parkinson's Disease • 25%
Schizophrenia • 25%
Published studies or clinical trial results